Answers are grounded in this paper and cite their sources.
Context. —Osteoclast-like giant cells (GCs) in giant cell tumors (GCTs) are thought to derive from a monocyte-macrophage lineage. Microphthalmia transcription factor (MITF) is necessary for osteoclast gene expression and tartrate-resistant acid phosphatase (TRAP) activation; c-Kit plays a role in regulation of MITF. Objective. —To gain insight into the differentiation of GCTs of bone (GCTBs) and GCTs tendon sheath ( GCTT Ss) by investigating immunohistochemical staining for c-Kit, MITF, TRAP, and HAM-56 in the GCs and stroma. Design. —Immunoreactivity for CD117 (c-Kit), MITF, TRAP, and HAM-56 was studied in 35 GCTBs, 15 GCTT Ss, and 5 foreign-body GC controls. Results. —Across tumors, MITF and TRAP but not c-Kit were generally expressed in GCs; TRAP was variably expressed in stromal cells. The MITF was expressed more consistently in stromal cells of GCTT Ss than GCTBs ( P < .001). The GCTBs showed more intense MITF stromal ( P < .001) and TRAP GC staining ( P = .04) than GCTT Ss. HAM-56 staining by stromal cells was associated with MITF stromal staining ( r 2 = 0.6, P < .001). Conclusions. —Results suggest that MITF and TRAP are expressed during osteoclast differentiation and that a proportion of mononuclear cells in GCTs express the macrophage marker HAM-56. Both GCTBs and GCTT Ss show similar patterns of immunohistochemical expression.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: